WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Private, Subsidiary
- Established
- 1891-01-01
- Employees
- 10K
- Market Cap
- -
Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies
Phase 1
Completed
- Conditions
- Resistant Solid Malignancies
- Interventions
- First Posted Date
- 2008-06-23
- Last Posted Date
- 2017-03-07
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 26
- Registration Number
- NCT00703625
- Locations
- πΊπΈ
Washington University School of Medicine, St. Louis, Missouri, United States
Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies
Phase 1
Completed
- Conditions
- Resistant Solid Malignancies
- Interventions
- First Posted Date
- 2008-06-23
- Last Posted Date
- 2013-05-24
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 28
- Registration Number
- NCT00703170
- Locations
- πΊπΈ
Washington University School of Medicine, St. Louis, Missouri, United States
Observational Study of Delayed Nausea and Vomiting
Completed
- Conditions
- Vomiting
- Interventions
- Behavioral: Functional Living Index - Emesis
- First Posted Date
- 2008-06-12
- Last Posted Date
- 2013-06-12
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 106
- Registration Number
- NCT00696280
- Locations
- πΊπΈ
Washington University School of Medicine, St. Louis, Missouri, United States
LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)
Phase 1
Completed
- Conditions
- Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
- Interventions
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2016-10-13
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 52
- Registration Number
- NCT00691938
- Locations
- πΊπΈ
Washington University, St. Louis, Missouri, United States
Hemodynamic Measurements During Liver Transplantation
Completed
- Conditions
- Liver Transplantation
- First Posted Date
- 2008-05-22
- Last Posted Date
- 2010-04-01
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 30
- Registration Number
- NCT00682110
- Locations
- πΊπΈ
Washington University School of Medicine, St. Louis, Missouri, United States
Study Evaluating Whether the Bispectral Index Prevents Patients at Higher Risk From Being Awake During Surgery and Anesthesia
Phase 4
Completed
- Conditions
- Explicit Recall of Intra-Operative Events
- Interventions
- Behavioral: Bispectral index protocolBehavioral: End tidal anesthetic gas-guided
- First Posted Date
- 2008-05-22
- Last Posted Date
- 2011-01-04
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 6000
- Registration Number
- NCT00682825
- Locations
- πΊπΈ
University of Chicago, Chicago, Illinois, United States
π¨π¦University of Manitoba, Winnipeg, Manitoba, Canada
πΊπΈWashington University, St Louis, Missouri, United States
Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma
Phase 2
Completed
- Conditions
- Rectal Carcinoma
- Interventions
- First Posted Date
- 2008-05-22
- Last Posted Date
- 2017-10-06
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 135
- Registration Number
- NCT00682786
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Evaluating the Effects of Surgical and Non-Surgical Treatment Options in People With Emphysema
Terminated
- Conditions
- EmphysemaPulmonary Disease, Chronic Obstructive
- First Posted Date
- 2008-05-09
- Last Posted Date
- 2021-12-02
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 802
- Registration Number
- NCT00675454
- Locations
- πΊπΈ
Washington University School of Medicine and Barnes-Jewish Hospital, Saint Louis, Missouri, United States
Evaluating Quality of Life for Patients With Chronic Obstructive Pulmonary Disease Who Are Undergoing Lung Transplantation
Terminated
- Conditions
- Pulmonary Disease, Chronic ObstructiveLung Transplantation
- First Posted Date
- 2008-05-09
- Last Posted Date
- 2018-12-28
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 419
- Registration Number
- NCT00675376
- Locations
- πΊπΈ
Washington University School of Medicine and Barnes-Jewish Hospital, Saint Louis, Missouri, United States
Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia
Phase 1
Completed
- Conditions
- Myelodysplastic Syndromes and Leukemia, Myeloid, Acute
- Interventions
- First Posted Date
- 2008-05-05
- Last Posted Date
- 2013-06-04
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 13
- Registration Number
- NCT00671697
- Locations
- πΊπΈ
Washington University, St. Louis, Missouri, United States
Β© Copyright 2025. All Rights Reserved by MedPath